Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Gene therapy programme launched for neurodegenerative diseases
Fri July 30th - An innovative gene therapy programme has been launched that could lead to novel treatments for neurodegenerative diseases. More
Unvaccinated pregnant women hospitalised with COVID-19
Fri July 30th - Pregnant women are being urged to have the COVID-19 vaccination after 200 were admitted to hospital last week with the virus – almost all of whom were unvaccinated. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Testosterone levels affect risk of metabolic disease and cancers

Tuesday February 11th, 2020

High testosterone levels may affect the risk of some metabolic diseases and cancers, according to the largest study to date on the genetic regulation of sex hormone levels.

The study, published last night (10 February 2020) in Nature Medicine, found that despite finding a strong genetic component to circulating testosterone levels in men and women, the genetic factors involved were different between the sexes.

Researchers from the UK Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge and the University of Exeter used genome wide association studies (GWAS) in 425,097 UK Biobank participants to identify 2,571 genetic variations associated with differences in the levels of testosterone and its binding protein sex-hormone binding globulin (SHGB).

They verified their genetic analyses in additional studies, including the EPIC-Norfolk study and Twins UK, and found a high level of agreement with their results in UK Biobank.

When they went on to use Mendelian randomisation, they found that in women, genetically high testosterone increases the risks of type 2 diabetes by 37 % and polycystic ovary syndrome (PCOS) by 51%. There were also increased risks of breast and endometrial cancers.

In men, they found high testosterone levels reduced type 2 diabetes in men by 14% and increased the risk of prostate cancer.

Joint senior author Dr John Perry, from the MRC Epidemiology Unit at the University of Cambridge, says: "Our findings that genetically higher testosterone levels increase the risk of PCOS in women is important in understanding the role of testosterone in the origin of this common disorder, rather than simply being a consequence of this condition.

“Likewise, in men testosterone-reducing therapies are widely used to treat prostate cancer, but until now it was uncertain whether lower testosterone levels are also protective against developing prostate cancer. Our findings show how genetic techniques such as Mendelian randomisation are useful in understanding of the risks and benefits of hormone therapies.”

Dr Katherine Ruth, of the University of Exeter, a lead author of the paper, adds: "Our findings provide unique insights into the disease impacts of testosterone.”

Ruth KS, Day FR, Tyrrell J et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nature Medicine 10 February 2020; doi: 10.1038/s41591-020-0751-5

Tags: Cancer | Diabetes | Men's Health | UK News | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)